Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.
Daly B, Nicholas K, Flynn J, Silva N, Panageas K, Mao JJ, Gazit L, Gorenshteyn D, Sokolowski S, Newman T, Perry C, Wagner I, Zervoudakis A, Salvaggio R, Holland J, Chiu YO, Kuperman GJ, Simon BA, Reidy-Lagunes DL, Perchick W. Daly B, et al. JAMA Netw Open. 2022 Mar 1;5(3):e221078. doi: 10.1001/jamanetworkopen.2022.1078. JAMA Netw Open. 2022. PMID: 35244701 Free PMC article.
Impact of minimal tumor burden on antibody response to vaccination.
Kim SK, Wu X, Ragupathi G, Gathuru J, Koide F, Cheung NK, Panageas K, Livingston PO. Kim SK, et al. Cancer Immunol Immunother. 2011 May;60(5):621-7. doi: 10.1007/s00262-011-0975-9. Epub 2011 Jan 26. Cancer Immunol Immunother. 2011. PMID: 21267719 Free PMC article.
Addressing racial and ethnic disparities in AACR project GENIE.
Sweeney SM, Lavery JA, Fuchs HE, Lee JA, Brown S, Panageas KS, Sawyers CL, Bedard PL. Sweeney SM, et al. Among authors: panageas ks. NPJ Precis Oncol. 2023 Aug 31;7(1):81. doi: 10.1038/s41698-023-00425-5. NPJ Precis Oncol. 2023. PMID: 37653066 Free PMC article. No abstract available.
Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies.
Brown S, Lavery JA, Shen R, Martin AS, Kehl KL, Sweeney SM, Lepisto EM, Rizvi H, McCarthy CG, Schultz N, Warner JL, Park BH, Bedard PL, Riely GJ, Schrag D, Panageas KS; AACR Project GENIE Consortium. Brown S, et al. Among authors: panageas ks. JAMA Oncol. 2022 Feb 1;8(2):287-291. doi: 10.1001/jamaoncol.2021.5153. JAMA Oncol. 2022. PMID: 34734967 Free PMC article.
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study.
Smithy JW, Kalvin HL, Ehrich FD, Shah R, Adamow M, Raber V, Maher CA, Kleman J, McIntyre DAG, Shoushtari AN, Betof Warner A, Callahan MK, Momtaz P, Eton O, Nair S, Wolchok JD, Chapman PB, Berger MF, Panageas KS, Postow MA. Smithy JW, et al. Among authors: panageas ks. Clin Cancer Res. 2024 May 20. doi: 10.1158/1078-0432.CCR-23-3643. Online ahead of print. Clin Cancer Res. 2024. PMID: 38767650
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Friedman JS, Durham BH, Reiner AS, Yabe M, Petrova-Drus K, Dogan A, Pulitzer M, Busam KJ, Francis JH, Rampal RK, Ulaner GA, Reddy R, Yeh R, Hatzoglou V, Lacouture ME, Rotemberg V, Mazor RD, Hershkovitz-Rokah O, Shpilberg O, Goyal G, Go RS, Abeykoon JP, Rech K, Morlote D, Fidai S, Gannamani V, Zia M, Abdel-Wahab O, Panageas KS, Rosenblum MK, Diamond EL. Friedman JS, et al. Among authors: panageas ks. Br J Haematol. 2024 Apr 12. doi: 10.1111/bjh.19462. Online ahead of print. Br J Haematol. 2024. PMID: 38613141
281 results